Friedreich's Ataxia NFZ — 36 facilities in 31 cities

Friedreich's ataxia is a rare hereditary neurodegenerative disease causing progressive impairment of movement coordination, speech, swallowing, and cardiomyopathy. Symptoms typically appear in childhood or adolescence. The NFZ covers genetic diagnostics, neurological rehabilitation, cardiological and orthopedic care. New therapies including omaveloxolone are becoming available through drug programs.